CNTA — CENTESSA PHARMACEUTICALS PLC

Ownership history in BRAIDWELL LP  ·  1 quarter on record

This page tracks every 13F SEC filing in which BRAIDWELL LP reported a position in CENTESSA PHARMACEUTICALS PLC (CNTA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.75% (2025 Q4)
Avg. % of fund
1.75%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 2,188,320 — — 1.75% $54.7M $25.01
% of Fund (quarterly)    CNTA price (monthly, adj. close)

Other funds also holding CNTA

As of 2025 Q4 — sorted by position size

Medicxi Ventures Management (Jersey) Ltd 3Y 59.8% GENERAL ATLANTIC, L.P. 3Y 7Y 5.33% STEMPOINT CAPITAL LP 4.95% 5AM Venture Management, LLC 3Y 4.57% First Light Asset Management, LLC 3Y 7Y 4.36% Avoro Capital Advisors LLC 3Y 7Y 3.58% TCG Crossover Management, LLC 3Y 3.55% EcoR1 Capital, LLC 3Y 7Y 3.53% Siren, L.L.C. 3.0% HighMark Wealth Management LLC 3Y 2.41%
← Back to BRAIDWELL LP Holdings